Skip to content

KORU Medical Systems KRMD Lease Liability Payments - Due Year Four

Lease Liability Payments - Due Year Four at other companies

Embecta Corp. logo
Embecta Corp.EMBC
$1.8M+5.9%
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
$153K
InfuSystem Holdings logo
InfuSystem HoldingsINFU
$818K-41.4%
UFP Technologies logo
UFP TechnologiesUFPT
$1.92M
ICU Medical logo
ICU MedicalICUI
$4.6M-36.6%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST

Other financials

Income statement

See full
Revenue$11.8M+22.1%
Gross profit$7.2M+19.6%
Operating income-$864.9K+30.5%
Net income-$807.1K+30.8%
EPS (diluted)-$0.02+33.3%

Balance sheet

See full
Cash & equivalents$8.8M+0.4%
Total debt$3.5M-2.8%
Total equity$16.9M+3.5%
Total assets$28.6M+5.1%

Cash flow

See full
Operating cash flow$14.7K+106%
CapEx$46.2K-89.6%
Free cash flow-$31.5K+95.4%

Valuation

See full
Market cap$206.24M+24.9%
Enterprise value$200.96M+25.1%
P/S4.8×+0.3×

Profitability

See full
Gross margin61.9%-1.6pp
Operating margin-6%-2.3pp
Net margin-5.3%-2.1pp
FCF margin-37.1%+23.7pp

Returns & leverage

See full
Return on equity-13.7%-4.8pp
Debt / equity0.2×0.0×
Current ratio2.3×-0.1×

Where this comes from

Reported directly by KORU Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour.

The official record: KORU Medical Systems’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about KORU Medical Systems's lease liability payments - due year four.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KORU Medical Systems's lease liability payments - due year four?
KORU Medical Systems (KRMD) reported lease liability payments - due year four of $553.76K in Q1 2026.
What does lease liability payments - due year four mean?
The contractual cash obligations for operating and finance leases due in the fourth year following the balance sheet date. This is part of the long-term lease maturity schedule that helps investors assess the company's future fixed cost burden. It allows for better modeling of long-term capital allocation and cash flow stability.